Harriet Edwards explores the current landscape for genome editing technologies
An article authored by Harriet Edwards, Associate Director of Regulatory Affairs at Boyds, has been published in Cell & Gene Therapy Insights. In the viewpoint article: ‘2024: the year of the genome editing technologies?’ Harriet looks at the current landscape for genome editing, the regulation surrounding it, and key considerations for regulators and developers as […]
